Literature DB >> 31721981

Responsiveness to Change and Establishment of the Minimal Clinically Important Difference for the Cutaneous Sarcoidosis Activity and Morphology Instrument.

Megan H Noe1,2, Joel M Gelfand1, Joshua S Bryer1, Sarah N Price1,3, Marc A Judson4, Misha Rosenbach1,5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31721981      PMCID： PMC6865242          DOI： 10.1001/jamadermatol.2019.3519

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

Review 1.  Minimal clinically important differences: review of methods.

Authors:  G Wells; D Beaton; B Shea; M Boers; L Simon; V Strand; P Brooks; P Tugwell
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

2.  Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data.

Authors:  M K A Basra; M S Salek; L Camilleri; R Sturkey; A Y Finlay
Journal:  Dermatology       Date:  2015-01-20       Impact factor: 5.366

3.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

4.  Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure.

Authors:  Marc A Judson; Michael Mack; Jennifer L Beaumont; Rosemary Watt; Elliot S Barnathan; David E Victorson
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

5.  Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis.

Authors:  George Wells; Tracy Li; Lara Maxwell; Ross MacLean; Peter Tugwell
Journal:  J Rheumatol       Date:  2007-02       Impact factor: 4.666

6.  Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.

Authors:  Misha Rosenbach; Howa Yeung; Emily Y Chu; Ellen J Kim; Aimee S Payne; Junko Takeshita; Carmela C Vittorio; Karolyn A Wanat; Victoria P Werth; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282
  6 in total
  3 in total

Review 1.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

2.  Stable Extent of Recurrently Active Cardiac and Cutaneous Sarcoidosis.

Authors:  Karen C Patterson; Misha Rosenbach; Paco E Bravo; Jacob G Dubroff
Journal:  Front Med (Lausanne)       Date:  2021-12-03

Review 3.  The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology-A Scoping Review.

Authors:  Reinhart Speeckaert; Arno Belpaire; Sandrine Herbelet; Marijn M Speeckaert; Nanja van Geel
Journal:  J Pers Med       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.